High-resistance inspiratory muscle strength training, or IMST, can help strengthen your breathing muscles. Practicing it for ...

Allrock Bio has dosed the first participants in a small clinical trial testing ROC-101 as an add-on treatment for pulmonary ...

Respiratory Drug Development: Comprehensive Strategies to Improve Data Quality, Upcoming Webinar Hosted by Xtalks ...

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW),a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced it will host the first of a series of live ...

Pulmonary hypertension (PH) is a progressive disease marked by pulmonary arterial remodeling and right ventricular dysfunction. The molecular mechanisms driving this remodeling, particularly ECM ...

Scientists have uncovered a surprising brain-based trigger for high blood pressure, tracing it to a small region in the brainstem that normally controls breathing. This area, which kicks in during ...

Pulmonary arterial hypertension, or PAH, is a rare and severe disease characterized by elevated blood pressure in the pulmonary arteries, which transport blood from the heart to the lungs. This can ...

The number doctors use to demarcate hypertension keeps going down, a trend applauded by many experts, who point to studies linking high blood pressure and dementia. By Paula Span The patient initially ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Last week, GSK agreed to acquire Canadian biotech 35Pharma for $950 million, adding a new pulmonary hypertension program to its respiratory and cardiopulmonary pipeline. The deal is built around HS235 ...